TRADE MARKS ACT 1995
DECISION OF A DELEGATE OF THE REGISTRAR OF TRADE MARKS WITH REASONS
Re:Opposition by Ferring BV to registration of trade mark application 1299321(5) - MEDIPURE – proceeding in the name of Pure Health Direct Pty Ltd.
Delegate: Iain Thompson Representation: Opponent: Ben Fitzpatrick of Counsel, instructed by Dawn Logan Keeffe of Davies Collison Cave.
Applicant: Written submissions by Cullen & CoDecision: 2011 ATMO 99
S52 opposition: sections 44, 58 and 59 – no ground establishedBackground
This matter arises out of the filing of an application to register a trade mark which proceeds in the name of Pure Health Direct Pty Ltd[1] (‘the applicant’) of Clontarf, Queensland. Current details of this application are:
Application No: 1299321
Priority Date: 15 May 2009Goods:Class 5: Dietetic substances adapted for medical use including dietetic foods and drinks; dietetic foods for use in conjunction with sports nutrition; dietetic foodstuffs and substances for invalids; functional foods being medicinal food having health promoting and/or disease-preventing property beyond basic nutrition; food for babies; food supplements for medical purposes; health food supplements made principally of minerals; health food supplements made principally of vitamins; medicated food supplements; medicated preparations for use as supplements for food; medicated supplements for food; medicated supplements for foodstuffs for human consumption; mineral dietary supplements for humans; mineral food-supplements; mineral supplements for foodstuffs for human consumption; mineral supplements to foodstuffs; nutritional supplements; nutritional supplements for medical use; fish and krill oils being nutritional supplements; plant compounds for use as dietary supplements (medicinal); herbal dietary supplements for special dietary requirements; supplements (trace element) for foodstuffs for human consumption; vitamin preparations in the nature of food supplement; vitamin supplements; vitamin supplements for foodstuffs for human consumption; protein foods for human consumption (adapted for medical purposes); protein preparations for use as additives to foodstuffs for human consumption (adapted for medical purposes); protein products for human consumption (adapted for medical purposes); aromatic teas (for medicinal use); herbs teas for medicinal purposes; sun screening preparations for medical purposes; suntanning preparations for medical use; sun skin care products for medical purposes
Trade Mark: MEDIPURE
[1] The application was filed by Yogie Lite Pty Ltd and the assignment of the trade mark to the applicant was recorded on 15 April 2010.
The application was examined in compliance with section 31 of the Trade Marks Act 1995 (‘the Act’) and advertised as accepted for possible registration in the Australian Official Journal of Trade Marks on 12 November 2009.
On 15 February 2010, after seeking and receiving an extension of time in which to do so, Ferring BV (‘the opponent’) of Hoofddorp, The Netherlands, served and filed Notice of Opposition (‘the Notice’) to the registration of the trade mark. The Notice includes all of the available grounds of opposition including those under sections 44, 58 and 59 which were subsequently argued at a hearing.
The hearing was before me as a delegate of the Registrar of Trade Marks in Sydney on 9 August 2011. Mr Ben Fitzpatrick…
Keep reading for free
Create a free CaseChat account to read Ferring BV v Pure Health Direct Pty Ltd and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2011] ATMO 99
- Decision Date
CaseChat Overview and Summary
The primary legal issue before the delegate was whether the opponent had established any grounds for opposing the registration of the applicant's trade mark. The opponent's evidence focused on its own trade mark, MENOPUR, and its use in the biopharmaceutical field, particularly in reproductive health. The opponent sought to demonstrate that its prior use and registration of MENOPUR internationally, and its efforts to register the mark in Australia for fertility-stimulating hormones, constituted grounds for opposition.
The delegate considered the evidence presented, including statutory declarations detailing the global registration and use of the MENOPUR trade mark by Ferring BV and its associated companies. However, the delegate noted that the opponent's evidence established that the goods for which MENOPUR was intended to be sold in Australia were not formally on the market at the priority date of the opposed application. Crucially, the delegate found that the opponent had not established a ground of opposition.
Consequently, the delegate decided to allow the trade mark application to proceed to registration, subject to the usual one-month period for appeal. The delegate also awarded costs to the applicant, as they were successful in the proceedings, to be assessed on the official scale.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.